Apixaban
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | <StructureSection load='2p16' size='350' side='right' caption='Factor Xa in Complex with the Inhibitor Apixaban' scene='95/953982/Cv/1'> | + | <StructureSection load='2p16' size='350' side='right' caption='Factor Xa in Complex with the Inhibitor Apixaban PDB cod [[2p16]].' scene='95/953982/Cv/1'> |
<scene name='95/953982/Cv/3'>Apixaban</scene>, sold under the brand name Eliquis, is an anticoagulant medication used to treat and prevent blood clots and to prevent stroke in people with nonvalvular atrial fibrillation through directly inhibiting [[Factor Xa]]. <scene name='95/953982/Cv/2'>Apixaban binding site</scene>. See also [https://en.wikipedia.org/wiki/Apixaban Apixaban] and [[Rivaroxaban]]. | <scene name='95/953982/Cv/3'>Apixaban</scene>, sold under the brand name Eliquis, is an anticoagulant medication used to treat and prevent blood clots and to prevent stroke in people with nonvalvular atrial fibrillation through directly inhibiting [[Factor Xa]]. <scene name='95/953982/Cv/2'>Apixaban binding site</scene>. See also [https://en.wikipedia.org/wiki/Apixaban Apixaban] and [[Rivaroxaban]]. | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 11:31, 21 January 2024
| |||||||||||
